⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for partially platinum sensitive

Every month we try and update this database with for partially platinum sensitive cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer PatientsNCT01624493
Ovarian Cancer
Carboplatin
Gemcitabine
Carboplatin
Gemcitabine
BNC105P
18 Years - Hoosier Cancer Research Network
BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer PatientsNCT01624493
Ovarian Cancer
Carboplatin
Gemcitabine
Carboplatin
Gemcitabine
BNC105P
18 Years - Hoosier Cancer Research Network
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsNCT02855944
Ovarian Cancer
Epithelial Ovar...
Fallopian Tube ...
Peritoneal Canc...
Chemotherapy
Rucaparib
18 Years - pharmaand GmbH
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsNCT02855944
Ovarian Cancer
Epithelial Ovar...
Fallopian Tube ...
Peritoneal Canc...
Chemotherapy
Rucaparib
18 Years - pharmaand GmbH
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: